(Q35206967)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941516%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

Software to compute and conduct sequential Bayesian phase I or II dose-ranging clinical trials with stopping rules (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941516%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

main subject

phase I clinical trial

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941516%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sylvie Chevret

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941516%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Sarah Zohar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941516%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Mathieu Taconnet

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941516%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941516%20AND%20SRC:MED&resulttype=core&format=json

Computer Methods and Programs in Biomedicine

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941516%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941516%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941516%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

117-125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941516%20AND%20SRC:MED&resulttype=core&format=json

Continual reassessment method: a practical design for phase 1 clinical trials in cancer.

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-2607%2802%2900120-7

7 January 2021

Methods for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-2607%2802%2900120-7

7 January 2021

The continual reassessment method in cancer phase I clinical trials: a simulation study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-2607%2802%2900120-7

7 January 2021

Practical modifications of the continual reassessment method for phase I cancer clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0169-2607%2802%2900120-7

7 January 2021

A comparison of two phase I trial designs.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-2607%2802%2900120-7

7 January 2021

Some practical improvements in the continual reassessment method for phase I studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-2607%2802%2900120-7

7 January 2021

An extension of the continual reassessment methods using a preliminary up-and-down design in a dose finding study in cancer patients, in order to investigate a greater range of doses.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-2607%2802%2900120-7

7 January 2021

An evaluation of phase I cancer clinical trial designs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-2607%2802%2900120-7

7 January 2021

Practical implementation of a modified continual reassessment method for dose-finding trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-2607%2802%2900120-7

7 January 2021

The continual reassessment method: comparison of Bayesian stopping rules for dose-ranging studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-2607%2802%2900120-7

7 January 2021

Integral evaluation for continual reassessment method.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-2607%2802%2900120-7

7 January 2021

A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-2607%2802%2900120-7

7 January 2021

Continual reassessment method: a likelihood approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-2607%2802%2900120-7

7 January 2021

An approach for dose finding of drugs in infants: sedation by midazolam studied using the continual reassessment method

1 reference

https://api.crossref.org/works/10.1016%2FS0169-2607%2802%2900120-7

7 January 2021

10.1016/S0169-2607(02)00120-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941516%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

DBLP publication ID

journals/cmpb/ZoharLTC03

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference